CPHI Barcelona 2023
Company

SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant in Europe (with variations all over the world), this exhibition welcomes operators from the fine chemicals and pharmaceutical industries.

The event’s 30 years of experience in connecting buyers and sellers of pharmaceutical products from across the global supply chain appealed to SyrHA!

Tickets in our pockets, suitcases packed, energy in our heart and a contagious smile on our lips… SyrHA team is going to Barcelona from 24 to 26 October 2023 to be part of this major event.

SyrHA wishes to present itself as a trusted partner, in the development and production of injectable medical devices, mainly based on Hyaluronic Acid, as CMO / CDMO (Contract Development and Manufacturing Organization).

We would like to showcase our latest products, Hyaluronic Acid solutions and manufacturing capabilities. These are products whose R&D is developed in our laboratory in Switzerland, then manufactured in our factory in France, in the form of hydrogel in a pre-filled syringe. Our injectable products are used by our customers in the field of aesthetics, dermatology, orthopedics, ophthalmology, and many others. 

We offer our clients support on different projects, according to their needs. Whether it’s technology transfer, raw material supply, generic products or the development of custom formulations, SyrHA stands by your side to offer you high-quality pharmaceutical medical devices.

Get in touch with us now for an interview at the CPHI in Barcelona

Do you have a project? Contact us

Explore our environment

  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…

  • Company

    Development of an innovative gel with very high concentration

    Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…

  • Company

    Technology transfer

    Our team relies on its many years of experience and past successes, to prepare and…

    Syrhatech - technology transfer
  • Company

    Development of a cross-linked HA formulation containing peptides

    At the request of our customer, this cross-linked HA product incorporates peptides for various therapeutic…

    Syrhatech - Value added technology
  • Company

    Development of a cross-linked hydrogel similar to an existing product

    Reverse engineering and formulation of cross-linked HA for specific (non-aesthetic) applications, and development of steam…

  • Company

    Formulation of a new polymer

    Technology transfer and development of a manufacturing process for a polysaccharide other than hyaluronic acid…

    Syrhatech - Who are we ?